These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 31166523)
1. Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the central-southern region of the state of Paraná - Brazil. Muller EV; Gimeno SGA Cien Saude Colet; 2019 May; 24(5):1903-1914. PubMed ID: 31166523 [TBL] [Abstract][Full Text] [Related]
2. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone. Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821 [TBL] [Abstract][Full Text] [Related]
3. Serum lipids and glucose abnormalities in HIV/AIDS patients on antiretroviral therapies. Salami AK; Akande AA; Olokoba AB West Afr J Med; 2009 Jan; 28(1):10-5. PubMed ID: 19662738 [TBL] [Abstract][Full Text] [Related]
4. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients. Domingos H; Cunha RV; Paniago AM; Martins DM; Elkhoury EB; Souza AS Braz J Infect Dis; 2009 Apr; 13(2):130-6. PubMed ID: 20140358 [TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy. Kazooba P; Kasamba I; Mayanja BN; Lutaakome J; Namakoola I; Salome T; Kaleebu P; Munderi P Pan Afr Med J; 2017; 27():40. PubMed ID: 28761616 [TBL] [Abstract][Full Text] [Related]
6. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients. Silva EF; Bassichetto KC; Lewi DS Arq Bras Cardiol; 2009 Aug; 93(2):113-8. PubMed ID: 19838487 [TBL] [Abstract][Full Text] [Related]
7. Management of metabolic complications and cardiovascular risk in HIV-infected patients. Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187 [TBL] [Abstract][Full Text] [Related]
8. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach. Oliveira RVC; Shimakura SE; Campos DP; Hökerberg YHM; Victoriano FP; Ribeiro S; Veloso VG; Grinsztejn B; Carvalho MS AIDS Care; 2018 May; 30(5):551-559. PubMed ID: 29058481 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD; AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520 [TBL] [Abstract][Full Text] [Related]
10. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. Koppel K; Bratt G; Eriksson M; Sandström E Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487 [TBL] [Abstract][Full Text] [Related]
14. [Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients]. Ena J; Benito C; Llácer P; Pasquau F; Amador C Med Clin (Barc); 2004 May; 122(19):721-6. PubMed ID: 15171905 [TBL] [Abstract][Full Text] [Related]
15. [First antiretroviral therapy regimen in HIV-infected patients. Durability and factors associated with therapy changes]. de la Torre J; Santos J; Perea-Milla E; Pérez I; Moreno F; Palacios R; Santamaría S; Del Arco A; Nuño E; Godoy M; Prada JL; Olalla J; Aguilar J; Martos F; Enferm Infecc Microbiol Clin; 2008; 26(7):416-22. PubMed ID: 18842236 [TBL] [Abstract][Full Text] [Related]
16. Lipodystrophy induced by combination antiretroviral therapy in HIV/AIDS patients: a Belgrade cohort study. Dragović G; Danilović D; Dimić A; Jevtović D Vojnosanit Pregl; 2014 Aug; 71(8):746-50. PubMed ID: 25181834 [TBL] [Abstract][Full Text] [Related]
17. Dyslipidemia in AIDS patients on highly active antiretroviral therapy. Nery MW; Martelli CM; Turchi MD Braz J Infect Dis; 2011; 15(2):151-5. PubMed ID: 21503402 [TBL] [Abstract][Full Text] [Related]
18. Metabolic changes associated with antiretroviral therapy in HIV-positive patients. Almeida SE; Borges M; Fiegenbaum M; Nunes CC; Rossetti ML Rev Saude Publica; 2009 Apr; 43(2):283-90. PubMed ID: 19225696 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy-associated diseases are common in the long-term. Lanzafame M; Lattuada E; Zoppini G; Vento S AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461 [No Abstract] [Full Text] [Related]
20. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults. Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]